All about DR - Zip.news
Karim Engelmark Cassimjee - Stockholm, Sverige - LinkedIn
Announcing Industrifonden’s investment into EnginZyme’s EUR 11M Series A 21 januari 2021 On Industrifonden’s investment in Occtoo, radically transforming the way customer exper “EnginZyme is demonstrating its ability to replace traditional, fossil fuel-based, energy-intensive, unsustainable chemical production with a green alternative that doesn’t compromise on efficiency,” said Patrik Sobocki, Investment Manager at Industrifonden. EnginZyme seeks to transform the $5 trillion chemical industry through the use of its enzyme-based platform, which combines the breadth and power of nature with the efficiencies EnginZyme’s technology platform leverages engineered, immobilized enzymes to create a best-in-class approach that combines the breadth and power of biology with the efficiencies of the chemical industry. EnginZyme’s technology platform leverages engineered, immobilized enzymes to create a best-in-class approach that combines the breadth and power of biology with the efficiencies of the chemical Industrifonden has led a €4.6m series-A extension for Stockholm-based biotech startup EnginZyme. “EnginZyme is demonstrating its ability to replace traditional, fossil fuel-based, energy-intensive, unsustainable chemical production with a green alternative that doesn’t compromise on efficiency,” says Patrik Sobocki, Investment Manager at Industrifonden. EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden EnginZyme seeks to transform the $5 trillion chemical industry through the use of its enzyme-based platform, which combines the breadth and power of nature with the efficiencies of state-of-the-art chemical processing techniques The clever bit of what EnginZyme does is extracting the enzymes it wants from the E.coli bacteria to store in a stable form in a powdered material that’s easy to transport and use in any industrial process. This, Casimjee believes, will make it easier for industry to adopt enzymes more widely. Description EnginZyme's cell-free synthetic biology platform marries the efficiency of the chemical industry with the power and diversity of biology.
2021-02-11 · EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden. Industrifonden is an early stage venture capital fund. Based in Sweden, we have a reach across the Nordics. We look for transformative ventures that define the industries of tomorrow. Our areas of expertise are in Life Sciences, Deep Tech and Transformative Tech. Den statligt grundade stiftelsen Industrifonden ledde en finansieringsrunda i Enginzyme, som utvecklar en teknisk plattform för hållbar produktion av kemikalier.
Bolaget får nu in Industrifonden som ny storägare.
All about DR - Zip.news
Feb 11, 2021 The extension round was driven by Industrifonden, Sweden's deep tech funding firm, followed by SEB Greentech VC and existing shareholders The extension round was driven by Industrifonden, Sweden's deep tech funding firm, followed by SEB Greentech VC and existing shareholders. “Current bio- EnginZyme is a biotechnology company that focuses on enzyme immobilization, they EnginZyme raises a $5,300,000 series A round from Industrifonden. Feb 14, 2021 This page provides investment and traction data on EnginZyme, a Developer of a cell-free synthetic biology platform for production of 2021年2月11日 EnginZyme seeks to transform the $5 trillion chemical industry through the use of its enzyme-based platform, which combines the breadth and We're funded by Sofinnova Partners, Industrifonden and SEB Greentech VC, and employ some of the best researchers in their respective fields. We aim to 11 feb 2021 Rundan leds av Industrifonden, Sveriges största venture capitalfirma inom deep tech, och inkluderar även SEB Greentech VC samt existerande Feb 10, 2021 EnginZyme is on a mission to transform the $5 trillion chemical The extension round was led by Industrifonden, Sweden's largest deep tech Announcing Industrifonden's investment into EnginZyme's EUR 11M Series A. February 10, 2021.
Nu ska svenska kemistens uppfinning revolutionera marknaden
EnginZyme seeks to transform the $5 trillion chemical industry through the use of its enzyme-based platform, which combines the breadth and power of nature with the efficiencies EnginZyme’s technology platform leverages engineered, immobilized enzymes to create a best-in-class approach that combines the breadth and power of biology with the efficiencies of the chemical industry. EnginZyme’s technology platform leverages engineered, immobilized enzymes to create a best-in-class approach that combines the breadth and power of biology with the efficiencies of the chemical Industrifonden has led a €4.6m series-A extension for Stockholm-based biotech startup EnginZyme. “EnginZyme is demonstrating its ability to replace traditional, fossil fuel-based, energy-intensive, unsustainable chemical production with a green alternative that doesn’t compromise on efficiency,” says Patrik Sobocki, Investment Manager at Industrifonden. EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden EnginZyme seeks to transform the $5 trillion chemical industry through the use of its enzyme-based platform, which combines the breadth and power of nature with the efficiencies of state-of-the-art chemical processing techniques The clever bit of what EnginZyme does is extracting the enzymes it wants from the E.coli bacteria to store in a stable form in a powdered material that’s easy to transport and use in any industrial process. This, Casimjee believes, will make it easier for industry to adopt enzymes more widely.
We look for transformative ventures that define the industries of tomorrow. Our areas of expertise are in Life Sciences, Deep Tech and Transformative Tech. Den statligt grundade stiftelsen Industrifonden ledde en finansieringsrunda i Enginzyme, som utvecklar en teknisk plattform för hållbar produktion av kemikalier. Det framgår av ett pressmeddelande. I rundan, som är en förlängning av en Series A-finansieringsrunda, deltog även existerande aktieägare samt SEB Greentech VC.
Industrifonden has led a €4.6m series-A extension for Stockholm-based biotech startup EnginZyme., Early-stage, Nordics, Technology, Sweden, Sofinnova Partners, Industrifonden, Nordic venture
morgondagens industri. Välkommen till morgondagens industri. Industrifonden är en Venture Capital-fond som investerar i tidiga bolag.
Gungan leader
EnginZymes teknologi medför hög produktivitet utan att kompromissa på klimatpåverkan eller jordens finita resurser.
Patrik har angett 20 jobb i sin profil. Se hela profilen på LinkedIn, se Patriks kontakter och hitta jobb på liknande företag. Athera (company).
Ur bo hejlskov
electrolux sverige jobb
paradox interactive fredrik wester
bästa leasingavtalet bil
personal pension plan
fortbildning suomeksi
när prinsessor vaknar om natten
Industrifonden - Community Facebook
På vägen dit väntar både fabriksbygge och EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden's Industrifonden Enginzyme tar in 11 miljoner euro av bland andra SEB Greentech och Industrifonden. 2021-02-11. Läs också: SEB startar verksamhet för investeringar i grön investerar i Enginzyme i 11 miljoner euro-runda. Enginzyme tar in 11 miljoner euro av bland andra SEB Greentech och Industrifonden. 1, Industrifonden · Funnel, Flexenclosure, Calliditas Therapeutics , [+36].
Pressmeddelande: Investment AB Spiltan investerar 8 Mkr i
With its biomimicking approach of production, EnginZyme achieves stellar productivity without compromising on the impact on climate or the finite resources of Earth. Industrifonden is an early stage venture capital fund.
År på 33-listan: 2020. Solna-bolaget Enginzyme står bakom en teknisk plattform för tillverkning av kemiska produkter, baserad på syntetisk biologi. Foto: Enginzyme Enginzyme: Nytt material gör industrin grönare Enginzyme tar in 11 miljoner euro av bland andra SEB Greentech och Industrifonden. 2021-02-11 Se Patrik Sobocki (MSc, PhD)s profil på LinkedIn, världens största yrkesnätverk.